Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Multi-level immune response network in mild-moderate Chronic Obstructive Pulmonary Disease (COPD).

Cruz T, López-Giraldo A, Noell G, Casas-Recasens S, Garcia T, Molins L, Juan M, Fernandez MA, Agustí A, Faner R.

Respir Res. 2019 Jul 12;20(1):152. doi: 10.1186/s12931-019-1105-z.

2.

Smoking Impairs the Immunomodulatory Capacity of Lung-Resident Mesenchymal Stem Cells in Chronic Obstructive Pulmonary Disease.

Cruz T, López-Giraldo A, Noell G, Guirao A, Casas-Recasens S, Garcia T, Saco A, Sellares J, Agustí A, Faner R.

Am J Respir Cell Mol Biol. 2019 Nov;61(5):575-583. doi: 10.1165/rcmb.2018-0351OC.

PMID:
30978114
3.

A comparison of sources of baseline data for treatments of problem behavior following a functional analysis.

Scheithauer M, Schebell SM, Mevers JL, Martin CP, Noell G, Suiter KC, Call NA.

J Appl Behav Anal. 2019 Mar 19. doi: 10.1002/jaba.549. [Epub ahead of print]

PMID:
30887502
4.

Do sputum or circulating blood samples reflect the pulmonary transcriptomic differences of COPD patients? A multi-tissue transcriptomic network META-analysis.

Faner R, Morrow JD, Casas-Recasens S, Cloonan SM, Noell G, López-Giraldo A, Tal-Singer R, Miller BE, Silverman EK, Agustí A, Hersh CP.

Respir Res. 2019 Jan 8;20(1):5. doi: 10.1186/s12931-018-0965-y.

5.

The impact of stimulus preference, order-effects, and treatment component omission in evaluating treatment integrity.

Lomas Mevers JE, Noell GH, Scheithauer M, Miller S, Alvarez JP, Fischer AJ.

J Sch Psychol. 2018 Aug;69:45-55. doi: 10.1016/j.jsp.2018.05.005. Epub 2018 May 22.

PMID:
30558753
6.

Teaching children with autism to tie their shoes using video prompt-models and backward chaining.

Richard PR 3rd, Noell GH.

Dev Neurorehabil. 2019 Nov;22(8):509-515. doi: 10.1080/17518423.2018.1518349. Epub 2018 Sep 13.

PMID:
30212261
7.

Distribution, temporal stability and association with all-cause mortality of the 2017 GOLD groups in the ECLIPSE cohort.

Faner R, Noell G, Badia JR, López-Giraldo A, Bakke P, Silverman EK, Tal-Singer R, Agustí A.

Respir Med. 2018 Aug;141:14-19. doi: 10.1016/j.rmed.2018.06.015. Epub 2018 Jun 19.

PMID:
30053959
8.

Bone marrow characterization in COPD: a multi-level network analysis.

Toledo-Pons N, Noell G, Jahn A, Iglesias A, Duran MA, Iglesias J, Rios A, Scrimini S, Faner R, Gigirey O, Agustí A, Cosío BG.

Respir Res. 2018 Jun 15;19(1):118. doi: 10.1186/s12931-018-0824-x.

9.

From systems biology to P4 medicine: applications in respiratory medicine.

Noell G, Faner R, Agustí A.

Eur Respir Rev. 2018 Feb 7;27(147). pii: 170110. doi: 10.1183/16000617.0110-2017. Print 2018 Mar 31. Review.

10.

Clinical News.

Hosgood S, Williams R, Brugada J, Agusti A, Faner R, Noell G.

Br J Hosp Med (Lond). 2018 Jan 2;79(1):8-11. doi: 10.12968/hmed.2018.79.1.8. No abstract available.

PMID:
29315044
11.

Lung function in early adulthood and health in later life: a transgenerational cohort analysis.

Agustí A, Noell G, Brugada J, Faner R.

Lancet Respir Med. 2017 Dec;5(12):935-945. doi: 10.1016/S2213-2600(17)30434-4. Epub 2017 Nov 14.

PMID:
29150410
12.

Azetidine and Piperidine Carbamates as Efficient, Covalent Inhibitors of Monoacylglycerol Lipase.

Butler CR, Beck EM, Harris A, Huang Z, McAllister LA, Am Ende CW, Fennell K, Foley TL, Fonseca K, Hawrylik SJ, Johnson DS, Knafels JD, Mente S, Noell GS, Pandit J, Phillips TB, Piro JR, Rogers BN, Samad TA, Wang J, Wan S, Brodney MA.

J Med Chem. 2017 Dec 14;60(23):9860-9873. doi: 10.1021/acs.jmedchem.7b01531. Epub 2017 Dec 5.

PMID:
29148769
13.

The EASI model: A first integrative computational approximation to the natural history of COPD.

Agustí A, Compte A, Faner R, Garcia-Aymerich J, Noell G, Cosio BG, Rodriguez-Roisin R, Celli B, Anto JM.

PLoS One. 2017 Oct 10;12(10):e0185502. doi: 10.1371/journal.pone.0185502. eCollection 2017.

14.

Multi-level differential network analysis of COPD exacerbations.

Noell G, Cosío BG, Faner R, Monsó E, Peces-Barba G, de Diego A, Esteban C, Gea J, Rodriguez-Roisin R, Garcia-Nuñez M, Pozo-Rodriguez F, Kalko SG, Agustí A.

Eur Respir J. 2017 Sep 27;50(3). pii: 1700075. doi: 10.1183/13993003.00075-2017. Print 2017 Sep.

15.

Evaluating an integrated support model for increasing treatment plan implementation following consultation in schools.

Noell GH, Volz JR, Henderson MY, Williams KL.

Sch Psychol Q. 2017 Dec;32(4):525-538. doi: 10.1037/spq0000195. Epub 2017 Feb 20.

PMID:
28221053
16.

Network Analysis of Lung Transcriptomics Reveals a Distinct B-Cell Signature in Emphysema.

Faner R, Cruz T, Casserras T, López-Giraldo A, Noell G, Coca I, Tal-Singer R, Miller B, Rodriguez-Roisin R, Spira A, Kalko SG, Agustí A.

Am J Respir Crit Care Med. 2016 Jun 1;193(11):1242-53. doi: 10.1164/rccm.201507-1311OC.

PMID:
26735770
17.

Discovery and preclinical profiling of 3-[4-(morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile (PF-06447475), a highly potent, selective, brain penetrant, and in vivo active LRRK2 kinase inhibitor.

Henderson JL, Kormos BL, Hayward MM, Coffman KJ, Jasti J, Kurumbail RG, Wager TT, Verhoest PR, Noell GS, Chen Y, Needle E, Berger Z, Steyn SJ, Houle C, Hirst WD, Galatsis P.

J Med Chem. 2015 Jan 8;58(1):419-32. doi: 10.1021/jm5014055. Epub 2014 Nov 17.

PMID:
25353650
18.

Kinase domain inhibition of leucine rich repeat kinase 2 (LRRK2) using a [1,2,4]triazolo[4,3-b]pyridazine scaffold.

Galatsis P, Henderson JL, Kormos BL, Han S, Kurumbail RG, Wager TT, Verhoest PR, Noell GS, Chen Y, Needle E, Berger Z, Steyn SJ, Houle C, Hirst WD.

Bioorg Med Chem Lett. 2014 Sep 1;24(17):4132-40. doi: 10.1016/j.bmcl.2014.07.052. Epub 2014 Jul 30.

PMID:
25113930
19.

Using performance feedback to enhance implementation fidelity of the problem-solving team process.

Burns MK, Peters R, Noell GH.

J Sch Psychol. 2008 Oct;46(5):537-50. doi: 10.1016/j.jsp.2008.04.001. Epub 2008 May 20.

PMID:
19083371
20.

Evaluating preference assessments for use in the general education population.

Resetar JL, Noell GH.

J Appl Behav Anal. 2008 Fall;41(3):447-51.

21.

Sequencing instructional tasks. A comparison of contingent and noncontingent interspersal of preferred academic tasks.

Noell GH, Whitmarsh EL, VanDerHeyden AM, Gatti SL, Slider NJ.

Behav Modif. 2003 Apr;27(2):191-216.

PMID:
12705105
22.

Increasing intervention implementation in general education following consultation: a comparison of two follow-up strategies.

Noell GH, Witt JC, LaFleur LH, Mortenson BP, Ranier DD, LeVelle J.

J Appl Behav Anal. 2000 Fall;33(3):271-84.

23.

Effects of contingent reward and instruction on oral reading performance at differing levels of passage difficulty.

Noell GH, Gansle KA, Witt JC, Whitmarsh EL, Freeland JT, LaFleur LH, Gilbertson DN, Northup J.

J Appl Behav Anal. 1998 Winter;31(4):659-63.

24.

CD5-mediated specific delivery of DNA to T lymphocytes: compartmentalization augmented by adenovirus.

Merwin JR, Carmichael EP, Noell GS, DeRome ME, Thomas WL, Robert N, Spitalny G, Chiou HC.

J Immunol Methods. 1995 Oct 26;186(2):257-66.

PMID:
7594625
25.

Targeted delivery of DNA using YEE(GalNAcAH)3, a synthetic glycopeptide ligand for the asialoglycoprotein receptor.

Merwin JR, Noell GS, Thomas WL, Chiou HC, DeRome ME, McKee TD, Spitalny GL, Findeis MA.

Bioconjug Chem. 1994 Nov-Dec;5(6):612-20.

PMID:
7873664
26.

Treatment integrity in applied behavior analysis with children.

Gresham FM, Gansle KA, Noell GH.

J Appl Behav Anal. 1993 Summer;26(2):257-63.

27.

Idiotypic analysis of human anti-topoisomerase I autoantibodies.

Hildebrandt S, Noell GS, Vazquez-Abad D, Earnshaw WC, Zanetti M, Rothfield NF.

Autoimmunity. 1991;10(1):41-8.

PMID:
1660312
28.

Autoantibodies to topoisomerase I (Scl-70): analysis by gel diffusion, immunoblot, and enzyme-linked immunosorbent assay.

Hildebrandt S, Weiner ES, Senecal JL, Noell GS, Earnshaw WC, Rothfield NF.

Clin Immunol Immunopathol. 1990 Dec;57(3):399-410.

PMID:
2173985
29.

[Therapy of disorders of myocardial metabolism with potassium-magnesium aspartate].

Reichertz PL, Noell G, Hemmati A.

Med Welt. 1967 Sep 23;38:2236-43. German. No abstract available.

PMID:
5614953
30.

[Experimental comparative studies in animals on the effect of D-thyroxine and D-triiodothyronine in alimentarily disturbed lipid metabolism].

Kessler FJ, Krüskemper HL, Noell G.

Arzneimittelforschung. 1967 Sep;17(9):1190-3. German. No abstract available.

PMID:
5632296
31.

[Clinical pharmacology of trienolones, a group of new anabolically actine aestrane-derivatives (4,9,11-oestratrien-17beta-ol-3-on)].

Krüskemper HL, Morgner KD, Noell G.

Arzneimittelforschung. 1967 Apr;17(4):449-54. German. No abstract available.

PMID:
5632439
32.

[Steroid structure and liver toxicity. Studies with C1- and C17-methylated androstane derivatives].

Krüskemper HL, Noell G.

Acta Endocrinol (Copenh). 1967 Jan;54(1):73-84. German. No abstract available.

PMID:
6071212
33.

Liver toxicity of a new anabolic agent: methyltrienolone (17-alpha-methyl-4,9,11-estratriene-17 beta-ol-3-one).

Krüskemper HL, Noell G.

Steroids. 1966 Jul;8(1):13-24. No abstract available.

PMID:
5955468
34.

[ON THE ROENTGENDIAGNOSIS OF BRONCHIAL CANCER. CAUSES OF FREQUENT MISDIAGNOSIS].

KESSLER FJ, NOELL G, BLUMENBERG FW.

Med Welt. 1965 May 8;19:1023-6. German. No abstract available.

PMID:
14304410
35.

[On the problem of age-related changes of the laryngeal mucosa].

NOELL G.

Arch Ohren Nasen Kehlkopfheilkd. 1962;179:361-5. German. No abstract available.

PMID:
14480187
36.

[Pulmonary hypertension caused by vascular neurofibromatosis of the lungs].

HAFERKAMP O, NOELL G.

Z Klin Med. 1962;157:61-7. German. No abstract available.

PMID:
13903541
37.

[On different forms of so-called "carcinoma in situ" in the larynx and tongue area].

NOELL G.

Arch Ohren Nasen Kehlkopfheilkd. 1961;179:100-10. German. No abstract available.

PMID:
13729417

Supplemental Content

Support Center